Where Are They Now

At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy.

BioCanRx is invested in our HQP by providing them with both the training and skills they need to be leaders in academia and industry.

David Cook
Scientist at the Ottawa Hospital Research Institute and Assistant Professor at the University of Ottawa

Etienne Melese

Landon Steenbakkers

Taha Azad
Assistant Professor, Université de Sherbrooke

Jessica Silva
Preclinical Immunology Scientist, NanoVation Therapeutics

Nikolas Martin
Lead of the Innovation Department, BMC

Gabrielle Siegers
Head of Research & Development, Helix BioPharma

Oliver Varette
Research Analyst, CADTH

Julian Smazynski
Research Associate, Deeley Research Centre

Alyssa Vito
Senior Scientist, Point Biopharma

James Han
Post-doctoral Scientist, Harvard University

Andrea Vervoort
Junior Data Scientist, Virica Biotech

Hayley McKay
Clinical Research Project Manager, SickKids

Rob Mould
Scientist, Ensoma

Brittany Umer
Senior Design Researcher, Bridgeable

Sarwat Khan
Senior Scientist, CMI (Cell-mediated Immunity) department, Nexelis

Piriya Yoganathan
Head of Research and Development, Biotherapeutics Manufacturing Centre – Virus Manufacturing Facility, OHRI

Marie-Laurence Tremblay
Research Ethics Board (REB) Manager, Nova Scotia Health Authority

Parvez Vora
Site Head, Century Therapeutics

Laura Evgin
Assistant Professor, UBC

Nicole Forbes
Scientific Projects Coordinator, Public Health Agency of Canada

Maartje Wouters
Freelance Medical Writer, Wouters Writing

Mélissa Mathieu
Senior Scientist, Caprion Biosciences

Noelle Wilton
Intern, BioMarin Pharmaceuticals